These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4700503)

  • 1. Liver cell dysplasia: a premalignant condition.
    Anthony PP; Vogel CL; Barker LF
    J Clin Pathol; 1973 Mar; 26(3):217-23. PubMed ID: 4700503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-cell dysplasia and hepatocellular carcinoma.
    Podda M; Roncalli M; Battezzati PM; Borzio M; Bruno S; Servida E; Coggi G
    Ital J Gastroenterol; 1992 Jan; 24(1):39-42. PubMed ID: 1315175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large cell dysplasia of hepatocytes, is it a premalignant condition?
    Kovács L; Elek G
    Acta Morphol Hung; 1987; 35(1-2):47-57. PubMed ID: 3124508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
    Cohen C; Derose PB
    Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
    Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
    Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precursor lesions for liver cancer in humans.
    Anthony PP
    Cancer Res; 1976 Jul; 36(7 PT 2):2579-83. PubMed ID: 776394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.
    Seki S; Sakaguchi H; Kitada T; Tamori A; Takeda T; Kawada N; Habu D; Nakatani K; Nishiguchi S; Shiomi S
    Clin Cancer Res; 2000 Sep; 6(9):3469-73. PubMed ID: 10999730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
    Lee RG; Tsamandas AC; Demetris AJ
    Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three types of liver cell dysplasia (LCD) in small cirrhotic nodules are distinguishable by karyometry and PCNA labelling, and their features resemble distinct grades of hepatocellular carcinoma.
    Zhao M; Zhang NX; Du ZY; Laissue JA; Zimmermann A
    Histol Histopathol; 1994 Jan; 9(1):73-83. PubMed ID: 7911690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver cell dysplasia: a premalignant condition.
    Anthony PP
    J Pathol; 1973 Jan; 109(1):Pxvii. PubMed ID: 4719769
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship.
    Nzeako UC; Goodman ZD; Ishak KG
    Am J Gastroenterol; 1996 May; 91(5):879-84. PubMed ID: 8633575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].
    Feng Z; He R; Lu Z; Ling Y
    Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
    Wu TT; Levy M; Correa AM; Rosen CB; Abraham SC
    Cancer; 2009 Oct; 115(19):4564-75. PubMed ID: 19670455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.